Information Library
Market analysis - Market Access
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
For Investigors: Market Situation
July 17, 2009
Learn about the clinical trial market situation. -
Poised for success
June 16, 2009
Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility -
James C. Kirk
March 25, 2009
Jim joined Eidetics in 1988 from senior management positions in consumer and industrial product marketing, strategy, and development positions at Ocean Spray Cranberries and Gillette Company. Previously at Ocean Spray, Jim successfully spearheaded the company’s new Ingredient Division. -
Jacco Keja, Ph.D.
March 25, 2009
Jacco joined Quintiles Consulting in 2007 as Practice Leader, Market Access. Previously, Jacco was responsible for building Organon's global and local competence in Strategic and Operational Pricing, as well as expanding Health Economics and Outcomes Research. -
John Doyle, Dr. PH
March 25, 2009
John was president and a founder of Analytica International a global reimbursement, outcomes and market access consulting firm. He previously led the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb. -
Matthew Eberhart
March 25, 2009
Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe. -
Jay Norman
March 24, 2009
President – Quintiles Consulting Jay brings 25 years of experience in the consulting industry and a strong track record of growth, most recently with Diamond Management and Technology Consultants, where he served as President and Chief Operating Officer. -
A New Gold Standard for Pricing
September 26, 2008
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (8 items)